Medtronic wins Japanese approval for MRI-safe pacemaker; Brazilian regulators gives companies extension;

@FierceMedDev: ICYMI: Power morcellation ban unlikely, but other FDA restrictions coming soon; includes email to FDA obtained by FMD. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI from FierceDrugDelivery: The new AstraZeneca, University of Manchester center for drug delivery becomes operational in February. More | Follow @VarunSaxena2

> Medtronic ($MDT) wins Japanese approval of the Evera MRI SureScan system implantable cardioverter-defibrillator system enabling MRI scans in patients with the device. Release

> Brazil's med tech regulator, ANVISA, is giving companies automatic extensions to comply with its new rules. More

Biotech News

@FierceBiotech: Biotech upstart Sage sees early efficacy for rare brain seizure drug. More | Follow @FierceBiotech

@JohnCFierce: From FierceBiotechResearch: Genentech R&D team fixes a flawed approach to Alzheimer's. Story | Follow @JohnCFierce

> Battered ArQule shares bump up on badly needed positive data for tivantinib. Article

> Fledgling Ziarco grabs a $33M transatlantic round for PhII atopic dermatitis drug. Story

> J&J chief hints at unease in China, but plots new buyouts. Item

> Merck's hepatitis C cocktail drug fails a 4-week challenge. Report

Pharma News

@FiercePharma: FDA tightens reins on equine compounding companies. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMI Friday: Fresenius Russian partnership tanks even as Russian tanks spotted rolling into Ukraine. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Eisai 'speechless' after another Fycompa price smack-down from Germany. More | Follow @CarlyHFierce

> J&J eyes dealmaking in China to ratchet up pharma sales. Article

> For sale: Bankrupt Dendreon and its laggard Provenge, for $275M or more. Any takers? More

CRO News

> India's GVK snags an early-stage CRO amid global growth. News

> Charles River deepens its ties to Huntington's R&D with new deal. Item

> FDA taps Icon to help patients better weigh in on trials. Story

> PPD dives into adaptive trials with Medidata deal. Report

> AMRI tanks on disappointing sales and a dimmer outlook. Article

Biotech IT News

> Google steps up Genomics pitch with $25-a-genome storage service. More

> Team taps Wikipedia for flu forecasting data. Story

> Open-source atlas of the human proteome goes live. Article

> FDA resumes its long search for a CIO. More

> AstraZeneca strikes $150M deal to buy data analysis business. Report

Animal Health News

> Jaguar postpones IPO amid rocky market for biotech and animal health offerings. Article

> Merck to meat industry: Zilmax is safe. Item

> FDA tightens reins on equine compounding companies. Report

> MWI shares sink despite better-than-expected earnings. Story

> Zoetis beats estimates on strength of livestock products and allergy drug for dogs. News

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.